biospecimen__admin__batch_number	345.53.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	C2E97090-9554-4035-964C-4B100C652A84
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-RG-A7D4-01A-12R
biospecimen__bio__bcr_portion_barcode	TCGA-RG-A7D4-01A-12
biospecimen__bio__bcr_sample_barcode	TCGA-RG-A7D4-01A
biospecimen__bio__biospecimen_barcode_bottom	0160357067
biospecimen__bio__day_of_creation	04
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	09
biospecimen__bio__month_of_shipment	10
biospecimen__bio__pathology_report_file_name	TCGA-RG-A7D4.C8724B8E-5FC3-419B-9CC8-E6046D671D96.pdf
biospecimen__bio__plate_column	6
biospecimen__bio__plate_id	A343
biospecimen__bio__plate_row	A
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	2
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-RG-A7D4
biospecimen__shared__patient_id	A7D4
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	66480110-9225-4ADB-A452-AF451BA2F1E3
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3
clinical__chol_lihc_shared__albumin_result_specified_value	3
clinical__chol_lihc_shared__albumin_result_upper_limit	5
clinical__chol_lihc_shared__bilirubin_lower_limit	1
clinical__chol_lihc_shared__bilirubin_upper_limit	1
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	1
clinical__chol_lihc_shared__creatinine_upper_limit	2
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	9
clinical__chol_lihc_shared__fetoprotein_outcome_value	5650
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis C
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	1
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	2
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Single
clinical__chol_lihc_shared__total_bilirubin_upper_limit	2
clinical__clin_shared__age_at_initial_pathologic_diagnosis	69
clinical__clin_shared__bcr_followup_barcode	TCGA-RG-A7D4-F71159
clinical__clin_shared__bcr_followup_uuid	ECDBEA25-F657-4FDE-9E2A-227F340245EE
clinical__clin_shared__cancer_first_degree_relative	2
clinical__clin_shared__day_of_form_completion	27
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	6
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	175
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2015
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2012
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	860d183f-fc7d-4b40-85fa-43ff7fecdfc2
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-RG-A7D4-01A-12R-A343-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	5728a07f-3e4d-4edb-a803-fb1984b18875
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.86
gdc__analytes__analyte_id	3ad2c915-0af5-4e57-a971-f186af4be4d6
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	08cbbb39-d05a-48b0-a966-5212c5923c8b
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:34:57.516354-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	ebf70d7c-a94a-56c0-beec-d0522f50c165
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	black or african american
gdc__demographic__year_of_birth	1943
gdc__diagnoses__age_at_diagnosis	25302
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-25302.0
gdc__diagnoses__days_to_last_follow_up	1098.0
gdc__diagnoses__diagnosis_id	b0cb03ba-9b4c-5326-99a4-c37ebc2f7581
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	29.407787993510006
gdc__exposures__exposure_id	0f74aa03-8e6e-5ac8-9cc4-d4fe46e5c550
gdc__exposures__height	172.0
gdc__exposures__weight	87.0
gdc__file_id	4b3f128e-7f2a-4744-b15d-0f1a7564322a
gdc__file_name	aa788683-c450-4324-b955-f9c37943622b.mirbase21.mirnas.quantification.txt
gdc__file_size	50404
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	6553831e76962faaff2af0e378786787
gdc__portions__is_ffpe	false
gdc__portions__portion_id	ce3cb839-11b8-4bbd-be79-cbe3b88cb95e
gdc__portions__portion_number	12
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	530
gdc__samples__initial_weight	250.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	C8724B8E-5FC3-419B-9CC8-E6046D671D96
gdc__samples__sample_id	20a2b10b-b7e3-4fe3-b8b6-ecbd4e91c5eb
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	20.0
gdc__slides__percent_monocyte_infiltration	2.0
gdc__slides__percent_necrosis	5.0
gdc__slides__percent_neutrophil_infiltration	2.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	30.0
gdc__slides__percent_tumor_cells	65.0
gdc__slides__percent_tumor_nuclei	70.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	f9a37353-40e4-4ebd-a955-db918ed77a4a
gdc__submitter_id	mirna_swap_dr11_206_MirnaExpression4cf28eee-4eac-4ea6-b089-22b39fa5e442_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	RG
gdc__tissue_source_site__name	Montefiore Medical Center
gdc__tissue_source_site__tissue_source_site_id	426f3759-b687-5b34-98fc-7b6e44c9c540
gdc__treatments__treatment_id	290f3c72-d366-5928-9d3d-8eaa9558fcbb
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:50.091+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/860d183f-fc7d-4b40-85fa-43ff7fecdfc2-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/860d183f-fc7d-4b40-85fa-43ff7fecdfc2-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129775
manually_curated__local_md5	6cc279f71287bd487bbd9d9b63723cda
manually_curated__opengdc_download_date	2018-10-16T17:11:20.000859+02:00
manually_curated__opengdc_file_md5	0219b830dfc96eae8fd82f0a3462d6e9
manually_curated__opengdc_file_size	50403
manually_curated__opengdc_id	860d183f-fc7d-4b40-85fa-43ff7fecdfc2-meq
manually_curated__origin_file_size	129775
manually_curated__origin_last_modified_date	Tue Oct 16 17:21:00 CEST 2018
manually_curated__origin_md5	6cc279f71287bd487bbd9d9b63723cda
manually_curated__tissue_status	tumoral
